Deetew: what you said. Great summary and I can't wait for 2020 to end and tax selling to stop. Although we will be able to sell in a few states, FDA is the key. They simply MUST come up with a regulatory pathway. They have stated that. Unfortunately, all of the worst case scenarios have occurred (no Nasdaq uplist because of the Mona stank, FDA not issuing an interim guidance, FDA issuing a BS all CBD products in the same category warning) but the company is still the same. Clinical Trial Application for the CBD gum coming in Q1 or Q2.
The worst-worst case scenario (i.e. FDA banning all CBD products) is not going to happen. FDA would piss off so many people and they really don't like to do that. They are not equipped with an updated DSHEA law to allow them to sell CBD as both a drug and a supplement. But when they decide that, they will have some rules that must be met and most of the 2700 companies marketing CBD (including Housewives of Orange County), will be out. Capital is drying up for bit players. Shelves will be cleared of ineffective products (but that takes a little time). CVSI will have a new marketing campaign and new products soon (e.g., a pet line). 2020 will be the year of a turnaround.
I never make price predictions but Baldingcontrarian is saying "maybe we make $2." Such a ridiculous statement. We should be $2 now based on financials, so it will be an easy jump there once we get FDA guidance.
If anyone thinks Duffy is not doing everything he can to help FDA with education about hemp and with a reasonable regulatory pathway, they are mistaken. Key new hires, Monas gone, no debt, drug program coming, new product line coming, this company will succeed.
Happy New Year to all.
MT
